APYX
Price
$1.16
Change
-$0.07 (-5.69%)
Updated
Apr 3 closing price
Capitalization
47.46M
34 days until earnings call
NVCR
Price
$16.98
Change
-$0.96 (-5.35%)
Updated
Apr 3 closing price
Capitalization
1.66B
27 days until earnings call
Ad is loading...

APYX vs NVCR

Header iconAPYX vs NVCR Comparison
Open Charts APYX vs NVCRBanner chart's image
Apyx Medical
Price$1.16
Change-$0.07 (-5.69%)
Volume$29.19K
Capitalization47.46M
NovoCure
Price$16.98
Change-$0.96 (-5.35%)
Volume$664.81K
Capitalization1.66B
APYX vs NVCR Comparison Chart
Loading...
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APYX vs. NVCR commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APYX is a Hold and NVCR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (APYX: $1.16 vs. NVCR: $16.98)
Brand notoriety: APYX and NVCR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: APYX: 80% vs. NVCR: 76%
Market capitalization -- APYX: $47.46M vs. NVCR: $1.66B
APYX [@Medical Specialties] is valued at $47.46M. NVCR’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APYX’s FA Score shows that 0 FA rating(s) are green whileNVCR’s FA Score has 1 green FA rating(s).

  • APYX’s FA Score: 0 green, 5 red.
  • NVCR’s FA Score: 1 green, 4 red.
According to our system of comparison, NVCR is a better buy in the long-term than APYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APYX’s TA Score shows that 4 TA indicator(s) are bullish while NVCR’s TA Score has 4 bullish TA indicator(s).

  • APYX’s TA Score: 4 bullish, 6 bearish.
  • NVCR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NVCR is a better buy in the short-term than APYX.

Price Growth

APYX (@Medical Specialties) experienced а -11.45% price change this week, while NVCR (@Medical Specialties) price change was -10.49% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.68%. For the same industry, the average monthly price growth was +1.30%, and the average quarterly price growth was +1.15%.

Reported Earning Dates

APYX is expected to report earnings on May 08, 2025.

NVCR is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Medical Specialties (-4.68% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCR($1.66B) has a higher market cap than APYX($47.5M). APYX YTD gains are higher at: -26.582 vs. NVCR (-43.020). APYX has higher annual earnings (EBITDA): -18.11M vs. NVCR (-177.45M). NVCR has more cash in the bank: 911M vs. APYX (43.7M). APYX has less debt than NVCR: APYX (38.5M) vs NVCR (596M). NVCR has higher revenues than APYX: NVCR (509M) vs APYX (52.3M).
APYXNVCRAPYX / NVCR
Capitalization47.5M1.66B3%
EBITDA-18.11M-177.45M10%
Gain YTD-26.582-43.02062%
P/E RatioN/AN/A-
Revenue52.3M509M10%
Total Cash43.7M911M5%
Total Debt38.5M596M6%
FUNDAMENTALS RATINGS
APYX vs NVCR: Fundamental Ratings
APYX
NVCR
OUTLOOK RATING
1..100
7374
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
7759
P/E GROWTH RATING
1..100
1007
SEASONALITY SCORE
1..100
1685

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APYX's Valuation (55) in the Medical Specialties industry is somewhat better than the same rating for NVCR (100). This means that APYX’s stock grew somewhat faster than NVCR’s over the last 12 months.

APYX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NVCR (100). This means that APYX’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's SMR Rating (97) in the Medical Specialties industry is in the same range as APYX (99). This means that NVCR’s stock grew similarly to APYX’s over the last 12 months.

NVCR's Price Growth Rating (59) in the Medical Specialties industry is in the same range as APYX (77). This means that NVCR’s stock grew similarly to APYX’s over the last 12 months.

NVCR's P/E Growth Rating (7) in the Medical Specialties industry is significantly better than the same rating for APYX (100). This means that NVCR’s stock grew significantly faster than APYX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APYXNVCR
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 12 days ago
85%
Bullish Trend 12 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTY30.34-0.22
-0.72%
Getty Realty Corp
GD269.62-6.42
-2.33%
General Dynamics Corp
OBDC14.40-0.38
-2.57%
Blue Owl Capital Corp
MSB25.73-1.10
-4.10%
Mesabi Trust
RANI1.30-0.09
-6.47%
Rani Therapeutics Holdings

APYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, APYX has been loosely correlated with CORBF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if APYX jumps, then CORBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APYX
1D Price
Change %
APYX100%
-5.69%
CORBF - APYX
36%
Loosely correlated
N/A
MKEAF - APYX
33%
Loosely correlated
N/A
AVGR - APYX
27%
Poorly correlated
N/A
QDEL - APYX
26%
Poorly correlated
-6.18%
NVCR - APYX
26%
Poorly correlated
-5.35%
More

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with FLGT. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then FLGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
-5.35%
FLGT - NVCR
35%
Loosely correlated
-3.52%
KIDS - NVCR
35%
Loosely correlated
-10.22%
NEO - NVCR
34%
Loosely correlated
-7.43%
TWST - NVCR
34%
Loosely correlated
-1.86%
BLFS - NVCR
34%
Loosely correlated
-5.63%
More